Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.8474 |
Intermediate Similarity |
NPD1038 |
Approved |
0.8232 |
Intermediate Similarity |
NPD4795 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD1739 |
Approved |
0.8214 |
Intermediate Similarity |
NPD1740 |
Approved |
0.8167 |
Intermediate Similarity |
NPD9705 |
Discontinued |
0.8167 |
Intermediate Similarity |
NPD112 |
Approved |
0.8163 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.8037 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.8018 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.798 |
Intermediate Similarity |
NPD4548 |
Discontinued |
0.798 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD1856 |
Discontinued |
0.7934 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD2187 |
Approved |
0.7931 |
Intermediate Similarity |
NPD5658 |
Approved |
0.7931 |
Intermediate Similarity |
NPD2189 |
Approved |
0.7923 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7874 |
Intermediate Similarity |
NPD6140 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD4429 |
Discontinued |
0.7828 |
Intermediate Similarity |
NPD3478 |
Clinical (unspecified phase) |
0.7828 |
Intermediate Similarity |
NPD3477 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.7794 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7748 |
Intermediate Similarity |
NPD4440 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD3402 |
Phase 1 |
0.7717 |
Intermediate Similarity |
NPD3006 |
Discontinued |
0.7689 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD9690 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7674 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD6643 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD1322 |
Clinical (unspecified phase) |
0.7653 |
Intermediate Similarity |
NPD1034 |
Phase 3 |
0.7653 |
Intermediate Similarity |
NPD1033 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD3939 |
Suspended |
0.7644 |
Intermediate Similarity |
NPD4502 |
Phase 2 |
0.7642 |
Intermediate Similarity |
NPD6961 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD4454 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD5999 |
Phase 2 |
0.7621 |
Intermediate Similarity |
NPD7222 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD565 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD4038 |
Approved |
0.761 |
Intermediate Similarity |
NPD4039 |
Approved |
0.761 |
Intermediate Similarity |
NPD4122 |
Approved |
0.761 |
Intermediate Similarity |
NPD4037 |
Approved |
0.761 |
Intermediate Similarity |
NPD32 |
Approved |
0.761 |
Intermediate Similarity |
NPD4036 |
Approved |
0.761 |
Intermediate Similarity |
NPD4035 |
Approved |
0.761 |
Intermediate Similarity |
NPD31 |
Approved |
0.761 |
Intermediate Similarity |
NPD4034 |
Approved |
0.761 |
Intermediate Similarity |
NPD4033 |
Approved |
0.7602 |
Intermediate Similarity |
NPD5256 |
Discontinued |
0.7588 |
Intermediate Similarity |
NPD4372 |
Phase 1 |
0.7588 |
Intermediate Similarity |
NPD6569 |
Phase 2 |
0.7579 |
Intermediate Similarity |
NPD1078 |
Clinical (unspecified phase) |
0.7573 |
Intermediate Similarity |
NPD3003 |
Approved |
0.757 |
Intermediate Similarity |
NPD4881 |
Clinical (unspecified phase) |
0.7559 |
Intermediate Similarity |
NPD3514 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD1258 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.7525 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7511 |
Intermediate Similarity |
NPD7067 |
Approved |
0.7511 |
Intermediate Similarity |
NPD7068 |
Approved |
0.75 |
Intermediate Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.7489 |
Intermediate Similarity |
NPD5022 |
Discontinued |
0.7489 |
Intermediate Similarity |
NPD3343 |
Phase 3 |
0.7487 |
Intermediate Similarity |
NPD4203 |
Approved |
0.7487 |
Intermediate Similarity |
NPD4204 |
Approved |
0.7476 |
Intermediate Similarity |
NPD4131 |
Phase 3 |
0.7474 |
Intermediate Similarity |
NPD6872 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD2582 |
Approved |
0.7473 |
Intermediate Similarity |
NPD2581 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6223 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7454 |
Intermediate Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD7452 |
Approved |
0.7452 |
Intermediate Similarity |
NPD7453 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1768 |
Approved |
0.7426 |
Intermediate Similarity |
NPD4418 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD424 |
Approved |
0.7421 |
Intermediate Similarity |
NPD425 |
Approved |
0.7415 |
Intermediate Similarity |
NPD484 |
Approved |
0.7409 |
Intermediate Similarity |
NPD6968 |
Phase 2 |
0.7409 |
Intermediate Similarity |
NPD6969 |
Phase 2 |
0.7409 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7404 |
Intermediate Similarity |
NPD5530 |
Phase 1 |
0.7398 |
Intermediate Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.7393 |
Intermediate Similarity |
NPD949 |
Phase 1 |
0.7384 |
Intermediate Similarity |
NPD4442 |
Phase 2 |
0.738 |
Intermediate Similarity |
NPD4558 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD4889 |
Approved |
0.7371 |
Intermediate Similarity |
NPD5903 |
Approved |
0.7371 |
Intermediate Similarity |
NPD5902 |
Approved |
0.7366 |
Intermediate Similarity |
NPD2176 |
Approved |
0.7366 |
Intermediate Similarity |
NPD4958 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD2175 |
Phase 3 |
0.7366 |
Intermediate Similarity |
NPD2177 |
Approved |
0.7363 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7363 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.7356 |
Intermediate Similarity |
NPD3397 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD5450 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD4921 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD4919 |
Phase 3 |
0.7337 |
Intermediate Similarity |
NPD4920 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5863 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1032 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD5601 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD7194 |
Discontinued |
0.7304 |
Intermediate Similarity |
NPD5644 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD5018 |
Phase 3 |
0.73 |
Intermediate Similarity |
NPD6257 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD8442 |
Discontinued |
0.7291 |
Intermediate Similarity |
NPD9695 |
Approved |
0.7277 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7277 |
Intermediate Similarity |
NPD2951 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1273 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD8512 |
Phase 3 |
0.7252 |
Intermediate Similarity |
NPD5479 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD5529 |
Phase 1 |
0.7251 |
Intermediate Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD706 |
Phase 1 |
0.7245 |
Intermediate Similarity |
NPD4072 |
Approved |
0.7245 |
Intermediate Similarity |
NPD4071 |
Approved |
0.724 |
Intermediate Similarity |
NPD6553 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD8403 |
Phase 1 |
0.7237 |
Intermediate Similarity |
NPD6473 |
Phase 1 |
0.7232 |
Intermediate Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD1923 |
Clinical (unspecified phase) |
0.7227 |
Intermediate Similarity |
NPD3938 |
Phase 1 |
0.7227 |
Intermediate Similarity |
NPD4890 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD3440 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3386 |
Phase 2 |
0.722 |
Intermediate Similarity |
NPD6131 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD4343 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD4344 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1418 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD1620 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD5930 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD6856 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD6202 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD3354 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD4885 |
Approved |
0.7177 |
Intermediate Similarity |
NPD5669 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7176 |
Intermediate Similarity |
NPD6147 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6590 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD1259 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD9689 |
Approved |
0.7156 |
Intermediate Similarity |
NPD2471 |
Approved |
0.7156 |
Intermediate Similarity |
NPD6494 |
Phase 2 |
0.7156 |
Intermediate Similarity |
NPD2472 |
Approved |
0.7156 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD5936 |
Approved |
0.715 |
Intermediate Similarity |
NPD5939 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8100 |
Phase 3 |
0.7137 |
Intermediate Similarity |
NPD7659 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD6290 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD5911 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7051 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD6568 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD6985 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD5632 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6306 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD1229 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD926 |
Approved |
0.7098 |
Intermediate Similarity |
NPD925 |
Approved |
0.7098 |
Intermediate Similarity |
NPD2780 |
Approved |
0.7098 |
Intermediate Similarity |
NPD2782 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7112 |
Discontinued |
0.7087 |
Intermediate Similarity |
NPD3395 |
Approved |
0.7087 |
Intermediate Similarity |
NPD3396 |
Approved |
0.7087 |
Intermediate Similarity |
NPD6251 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7085 |
Intermediate Similarity |
NPD2600 |
Approved |
0.7085 |
Intermediate Similarity |
NPD2599 |
Approved |
0.7085 |
Intermediate Similarity |
NPD2601 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2616 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD2615 |
Phase 3 |
0.7078
|
Intermediate Similarity |
NPD3763 |
Approved |